Access cutting-edge dry mouth treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access dry mouth specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related dry mouth treatment provided free
This is a first-in-human clinical study to evaluate the safety, tolerability and efficacy of RXRG001 administered in the ducts of the parotid glands in adult patients with radiation-induced xerostomia (dry mouth) and hyposalivation (reduced saliva production). In Part 1 of the study (open-label, single-arm), patients will receive unilateral administrations of RXRG001 in 3 single ascending dose cohorts and in 3 multiple ascending dose cohorts. Part 2 of the study has a randomized, double-blind,
Sponsor: RiboX Therapeutics Ltd.
Check if you qualify for this dry mouth clinical trial in Iowa City, IA
If you're searching for dry mouth treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dry mouth specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.